Genetic variability of Polish serogroup B meningococci (2010–2016) including the 4CMenB vaccine component genes. Issue 8 (18th February 2020)

• Record Type: Journal Article
• Authors: Waśko, Izabela; Gołębiewska, Agnieszka; Kiedrowska, Marlena; Ronkiewicz, Patrycja; Wróbel-Pawelczyk, Izabela; Kuch, Alicja; Hong, Eva; Skoczyńska, Anna
• Is Part Of: Vaccine. Volume 38:Issue 8(2020)
• Page Start: 1943
• Page End: 1952
• Publication Date: 2020-02-18
• Subjects: Neisseria meningitidis -- invasive meningococcal disease -- molecular epidemiology -- Bexsero® Antigen Sequence Type; Vaccines -- Periodicals; 615.372
• DOI: 10.1016/j.vaccine.2020.01.021
• Languages: English
• ISSNs: 0264-410X

Abstract

Abstract: Neisseria meningitidis serogroup B (MenB) has recently become the major cause of invasive meningococcal disease in Poland. Therefore, the purpose of this study was to characterize MenB isolates, responsible for invasive meningococcal disease in 2010–2016, by MLST and sequencing of genes encoding proteins used as 4CMenB vaccine antigens. Two methods of coverage estimation were performed: extrapolation of MATS results of Polish meningococci 2010–2011 (exMATS) and gMATS, which combines genotyping and MATS results. Among 662 isolates 20 clonal complexes (CC) were detected, of which the most frequent were CC32, CC41/44 and CC18, accounting for 31.9%, 16.5% and 12.7%, respectively. A total of 111 combinations of PorA variable regions (VR1/VR2) were found, with P1.7, 16 (15.0%) and P1.22, 14 (13.6%) being prevalent. Vaccine variant VR2:4 was detected in 7.3% of isolates, mainly representing CC41/44 and non-assigned CC. Eighty five fHbp alleles encoding 74 peptide subvariants were revealed. Subvariant 1.1, a component of 4CMenB, was prevalent (24.2%) and found generally in CC32. Typing of the nhba gene revealed 102 alleles encoding 87 peptides. The most frequent was peptide 3 (22.4%), whereas vaccine peptide 2 was detected in 9.8%, mostly among CC41/44. The nadA gene was detected in 34.0% of isolates and the most prevalent was peptide 1 (variant NadA-1; 71.6%), found almost exclusively in CC32 meningococci. Vaccine peptide 8 (variant NadA-2/3) was identified once. Consequently, 292 completed BAST profiles were revealed. Regarding vaccine coverage, 39.7% of isolates had at least one 4CMenB vaccine variant, but according to exMATS and gMATS the coverage was 83.3% and 86.6%, respectively. In conclusion, Polish MenB (2010–2016) was highly diverse according to MLST and gene alleles encoding 4CMenB vaccine antigens. Some correlations between clonal complexes and variants of examined proteins/BAST profiles were revealed and a high coverage of 4CMenB vaccine was estimated.